These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25737783)

  • 1. The value of serum midkine level in diagnosis of hepatocellular carcinoma.
    Shaheen KY; Abdel-Mageed AI; Safwat E; AlBreedy AM
    Int J Hepatol; 2015; 2015():146389. PubMed ID: 25737783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.
    Zhu WW; Guo JJ; Guo L; Jia HL; Zhu M; Zhang JB; Loffredo CA; Forgues M; Huang H; Xing XJ; Ren N; Dong QZ; Zhou HJ; Ren ZG; Zhao NQ; Wang XW; Tang ZY; Qin LX; Ye QH
    Clin Cancer Res; 2013 Jul; 19(14):3944-54. PubMed ID: 23719264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.
    Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J
    PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients.
    El-Shayeb AF; El-Habachi NM; Mansour AR; Zaghloul MS
    Medicine (Baltimore); 2021 Apr; 100(17):e25112. PubMed ID: 33907088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum midkine levels for the diagnosis and assessment of response to interventional therapy in patients with hepatocellular carcinoma.
    Zheng L; Li H; Huang J; Shin J; Luo S; Guo C; Zhao Y; Li F
    J Interv Med; 2021 Feb; 4(1):39-45. PubMed ID: 34805946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular Carcinoma.
    Hodeib H; ELshora O; Selim A; Sabry NM; El-Ashry HM
    Electron Physician; 2017 Jan; 9(1):3492-3498. PubMed ID: 28243398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of diagnostic accuracy of Midkine and AFP for detecting hepatocellular carcinoma: a systematic review and meta-analysis.
    Lu Q; Li J; Cao H; Lv C; Wang X; Cao S
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker.
    Christou C; Stylianou A; Gkretsi V
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA Interference based Midkine Gene Therapy for Hepatocellular Carcinoma.
    Mamdouh S; Khorshed FEM; Hammad G; Magdy M; Abdelraouf A; Hemida E; Shemis M
    Asian Pac J Cancer Prev; 2024 Jul; 25(7):2371-2379. PubMed ID: 39068570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of Midkine and AFP in the detection of hepatocellular carcinoma: A systematic review and meta-analysis.
    Lubis M; Darmadi D; Samuel Surja S; Pakpahan C
    Caspian J Intern Med; 2024; 15(4):559-569. PubMed ID: 39359432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.
    Jia HL; Ye QH; Qin LX; Budhu A; Forgues M; Chen Y; Liu YK; Sun HC; Wang L; Lu HZ; Shen F; Tang ZY; Wang XW
    Clin Cancer Res; 2007 Feb; 13(4):1133-9. PubMed ID: 17317821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and Prognostic Value of Talin-1 and Midkine as Tumor Markers in Hepatocellular Carcinoma in Egyptian Patients.
    Mashaly AH; Anwar R; Ebrahim MA; Eissa LA; El Shishtawy MM
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1503-1508. PubMed ID: 29936723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.
    Gowhari Shabgah A; Ezzatifar F; Aravindhan S; Olegovna Zekiy A; Ahmadi M; Gheibihayat SM; Gholizadeh Navashenaq J
    IUBMB Life; 2021 Apr; 73(4):659-669. PubMed ID: 33625758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
    Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
    Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis.
    Ismail SA; El Saadany Sh; Ziada DH; Zakaria SS; Mayah WW; Elashry H; Arafa M; Elmashad N
    Asian Pac J Cancer Prev; 2017 Apr; 18(4):1105-1111. PubMed ID: 28547948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.
    El-Abd N; Fawzy A; Elbaz T; Hamdy S
    Tumour Biol; 2016 Jan; 37(1):211-6. PubMed ID: 26189841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.